TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32414580

Group type: EXPERIMENTAL
Intervention: IV glibenclamide
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Osmotherapy
Number of subjects: 77
Study: 616062859

Group type: EXPERIMENTAL
Intervention: Mitosis Kinase Score (MKS) assessed at surgery
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: p21 expression at surgery
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Combination of MKS and p21
Number of subjects: 417
Study: 36435551

Group type: EXPERIMENTAL
Intervention: Instrumental behavior providing 100% contingency information about aversive or neutral events
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instrumental behavior providing 50% contingency information
Number of subjects: 0
Study: 34554308

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Locking plate (LP)
Number of subjects: 99
Study: 32469922

Group type: EXPERIMENTAL
Intervention: Community Navigator programme over six months in addition to routine care (n = 30)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine care (n = 10)
Number of subjects: 40
Study: 35835904

Group type: EXPERIMENTAL
Intervention: Oncofertility education based on the naturalistic decision-making (NDM) model
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-oncofertility education
Number of subjects: 84
Study: 32840151

Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 36221141

Group type: EXPERIMENTAL
Intervention: Passive Digital Marker (PDM)
Number of subjects: 7200

Group type: EXPERIMENTAL
Intervention: Passive Digital Marker (PDM) with Quick Dementia Rating Scale (QDRS)
Number of subjects: 7200

Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 7200
Study: 33528063

Group type: EXPERIMENTAL
Intervention: First-line treatments (various types including chemotherapy and radiotherapy)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CH) and radiotherapy (RT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CH) only
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Stage IV patients
Number of subjects: 85
Study: 32019488

Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum (8 mmHg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard pressure pneumoperitoneum (12 mmHg)
Number of subjects: 44
Study: 35226083

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel plus bevacizumab
Number of subjects: 519

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel plus placebo
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel (group C)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Mastectomy with radiation
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Asian, Black, or American Indian or Alaska Native race
Number of subjects: 519
Study: 33754828

Group type: EXPERIMENTAL
Intervention: Deep learning-based detection (DLD) system
Number of subjects: 228

Group type: COMPARATOR
Intervention: Pooled observers
Number of subjects: 228
Study: 35610625

Group type: EXPERIMENTAL
Intervention: Elian Granules (24.2 g, two small bags, twice a day for 24 weeks)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (two small bags, twice a day for 24 weeks)
Number of subjects: 240
Study: 32557000

Group type: EXPERIMENTAL
Intervention: Combination therapy (fractional 2940-nm Er:YAG laser + 5% amorolfine lacquer)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy (5% amorolfine lacquer)
Number of subjects: 0
Study: 35266202

Group type: EXPERIMENTAL
Intervention: Pneumatic jet injection (PJI) with 5-fluorouracil (5-FU) and triamcinolone acetonide (TAC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PJI with TAC + 5-FU
Number of subjects: 20
Study: 33004742

Group type: EXPERIMENTAL
Intervention: MRI-guided microwave ablation (MWA)
Number of subjects: 43

Group type: COMPARATOR
Intervention: CT-guided microwave ablation (MWA)
Number of subjects: 43
Study: 34021767

Group type: EXPERIMENTAL
Intervention: High Level of Confidence (LOC)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Moderate Level of Confidence (LOC)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low Level of Confidence (LOC)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Critically Low Level of Confidence (LOC)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Consort Adherence Score (CAS)
Number of subjects: 250
Study: 33225808

Group type: EXPERIMENTAL
Intervention: MRT (modified rolling hitch with tape)
Number of subjects: 40

Group type: COMPARATOR
Intervention: MRS (modified rolling hitch with suture)
Number of subjects: 40

Group type: COMPARATOR
Intervention: MPS (modified Prusik knot with suture)
Number of subjects: 40

Group type: COMPARATOR
Intervention: MPT (modified Prusik knot with tape)
Number of subjects: 40
Study: 32615777

Group type: EXPERIMENTAL
Intervention: Cookstove air pollution exposure
Number of subjects: 48

Group type: COMPARATOR
Intervention: Filtered-air control
Number of subjects: 48
Study: 33430955

Group type: COMPARATOR
Intervention: COAST only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: COAST plus external facilitation (EF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: COAST plus EF and internal facilitation (EF/IF)
Number of subjects: 0
Study: 34686629

Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation stretching
Number of subjects: 36

Group type: COMPARATOR
Intervention: Health lecture series (Control)
Number of subjects: 36
Study: 32552310

Group type: EXPERIMENTAL
Intervention: Narrative approach to public health communication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Narrative detailing a description of the evidence delivered by a healthcare professional
Number of subjects: 0
Study: 33499847

Group type: EXPERIMENTAL
Intervention: 50 mg/kg ART (ig) treatment diabetic
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 100 mg/kg ART (ig) treatment diabetic
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6 U/kg insulin (iH) treatment diabetic
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diabetic control group
Number of subjects: 40
Study: 33761461

Group type: EXPERIMENTAL
Intervention: High-load (HL) half-squat priming (87% 1RM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Moderate-load (ML) half-squat priming (65% 1RM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 15
Study: 32567238

Group type: EXPERIMENTAL
Intervention: YiqiFumai lyophilized injection (5.2 g/day)
Number of subjects: 1270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1270
Study: 33219590

Group type: EXPERIMENTAL
Intervention: Dry topical heat for 7 min using two hot seed bags (N=21)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Controlled pressure from a sphygmomanometer inflated to 100 mmHg (N=18)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Combination of heat and pressure (N=20)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard tourniquet around the upper arm (control)
Number of subjects: 59
Study: 32221332

Group type: EXPERIMENTAL
Intervention: Sodium picosulfate/magnesium citrate (PSMC) preparation-Bowklean
Number of subjects: 631

Group type: COMPARATOR
Intervention: Klean-Prep/Dulcolax
Number of subjects: 631
Study: 35768736

Group type: EXPERIMENTAL
Intervention: Intravenous cefazolin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intravenous clindamycin
Number of subjects: 16
Study: 34405393

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (ATRA) plus oral arsenic (realgar-indigo naturalis formula)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (ATRA) plus arsenic trioxide
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: PML-RARA transcript level of ≥6.5% at the end of induction therapy
Number of subjects: 212
Study: 35461558

Group type: EXPERIMENTAL
Intervention: Segmentectomy
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 1106
Study: 32067615

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 542

Group type: COMPARATOR
Intervention: Control group (no PPIs)
Number of subjects: 542
Study: 35162375

Group type: EXPERIMENTAL
Intervention: EQ-5D-3L
Number of subjects: 577
Study: 33397316

Group type: EXPERIMENTAL
Intervention: Narrative and Skills‐building Intervention (NSI)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 208
Study: 32203696

Group type: EXPERIMENTAL
Intervention: Tumour bed boost
Number of subjects: 1208

Group type: COMPARATOR
Intervention: Conventional whole breast radiotherapy
Number of subjects: 1208
Study: 34687036

Group type: EXPERIMENTAL
Intervention: Progressive aerobic exercise (PAE) for 24 weeks, 2 supervised sessions per week, 30–60 minutes at 65–95% of maximum heart rate.
Number of subjects: 86

Group type: COMPARATOR
Intervention: Waitlist control group (24 weeks of habitual lifestyle) followed by PAE.
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Progressive aerobic exercise (PAE) for 24 weeks.
Number of subjects: 86
Study: 34711072

Group type: EXPERIMENTAL
Intervention: Transitional care services
Number of subjects: 2494

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2494
Study: 33354979

Group type: EXPERIMENTAL
Intervention: Assessment of Brief Behavioural Change Counselling (ABC tool)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Assessment of Brief Behavioural Change Counselling (ABC tool) - sub-scores
Number of subjects: 6
Study: 35297691

Group type: EXPERIMENTAL
Intervention: Equation group (EG) using portable method to measure sweat rate (SR)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Validation group (VG) using portable method to measure sweat rate (SR)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combined data from both groups
Number of subjects: 32
Study: 33020898

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone 100 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Oral progesterone 400 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Matching transdermal/oral placebo
Number of subjects: 14
Study: 33104729

Group type: EXPERIMENTAL
Intervention: Familiar condition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 20
Study: 35751508

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash (MW)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33357674

Group type: EXPERIMENTAL
Intervention: Increased body weight (BW) trajectories (up to 22.5% above recommended target)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Increased body weight (BW) trajectories
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Feed-restricted birds
Number of subjects: 36

Group type: COMPARATOR
Intervention: Unrestricted birds
Number of subjects: 36
Study: 35133701

Group type: EXPERIMENTAL
Intervention: Probiotic mouth rinse (Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium longum, Saccharomyces boulardii)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic mouth rinse
Number of subjects: 60
Study: 32559734

Group type: EXPERIMENTAL
Intervention: Diabetic-diet with low-fructose for 8 weeks
Number of subjects: 50
Study: 36052175

Group type: EXPERIMENTAL
Intervention: Strength training (ST) high volume (3 sets per exercise) + photobiomodulation therapy (PBMt)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Strength training (ST) low volume (1 set per exercise) + photobiomodulation therapy (PBMt)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Strength training (ST) high volume (3 sets per exercise) + placebo
Number of subjects: 48

Group type: COMPARATOR
Intervention: Strength training (ST) low volume (1 set per exercise) + placebo
Number of subjects: 48
Study: 32989456

Group type: EXPERIMENTAL
Intervention: Statin use (≥5 years)
Number of subjects: 752469

Group type: EXPERIMENTAL
Intervention: Statin use (intention-to-treat)
Number of subjects: 752469

Group type: EXPERIMENTAL
Intervention: Statin use (per-protocol)
Number of subjects: 752469

Group type: COMPARATOR
Intervention: Previous case-control analytical approaches
Number of subjects: 752469
Study: 35675605

Group type: EXPERIMENTAL
Intervention: Synthetic osmotic cervical dilator
Number of subjects: 307

Group type: COMPARATOR
Intervention: Oral misoprostol
Number of subjects: 307
Study: 34169551

Group type: EXPERIMENTAL
Intervention: Adjunct use of deproteinized bovine bone mineral (DBBM) and native bilayer collagen membrane (NBCM)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Surgical debridement
Number of subjects: 66
Study: 33292887

Group type: EXPERIMENTAL
Intervention: Fructose (42g/day in low fat muffins)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sucrose (42g/day in low fat muffins)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fructose and Sucrose (both types consumed)
Number of subjects: 28
Study: 35987208

Group type: EXPERIMENTAL
Intervention: Point-of-care viral load testing every 3 months, targeted drug resistance mutation testing, and clinical decision support.
Number of subjects: 704

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Point-of-care viral load testing.
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Targeted drug resistance mutation testing in intervention participants.
Number of subjects: 704
Study: 33986070

Group type: EXPERIMENTAL
Intervention: Short duration treatment strategy (antibiotics may be stopped as early as day 3 if respiratory cultures are negative, and day 5 if positive)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Standard-of-care duration arm (antibiotics for at least 8 days)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Short duration treatment strategy
Number of subjects: 460
Study: 35587457

Group type: EXPERIMENTAL
Intervention: Weekly intramuscular (IM) 17 hydroxyprogesterone (17‐OHP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 17‐OHP
Number of subjects: 0
Study: 34459574

Group type: EXPERIMENTAL
Intervention: Blood flow restriction exercise (BFR) for 4 weeks prior to surgery
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard of care (no exercise)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Blood flow restriction exercise (BFR)
Number of subjects: 10
Study: 35261049

Group type: EXPERIMENTAL
Intervention: High-performance inulin (HPI)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Oligofructose-enriched inulin (OEI)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 35450573

Group type: EXPERIMENTAL
Intervention: Metoprolol 150 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 32697847

Group type: EXPERIMENTAL
Intervention: TEACH intervention (nurse care manager, interactive electronic registry, opioid education, academic detailing, access to addiction specialists)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: TEACH intervention
Number of subjects: 187
Study: 32369569

Group type: EXPERIMENTAL
Intervention: Collagen Matrix Seal (CMS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Collagen Sponge (CS)
Number of subjects: 28
Study: 35469810

Group type: EXPERIMENTAL
Intervention: Aquablation (WATER)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Aquablation (WATER II)
Number of subjects: 217
Study: 34397949

Group type: EXPERIMENTAL
Intervention: Ropivacaine with dexmedetomidine (RD)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Ropivacaine with nalbuphine (RN)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ropivacaine (RC)
Number of subjects: 102
Study: 34686445

Group type: EXPERIMENTAL
Intervention: CT-P10
Number of subjects: 258

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 258
Study: 33471629

Group type: EXPERIMENTAL
Intervention: Two Way Prayer Meditation (TWPM)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 134
Study: 36111381

Group type: EXPERIMENTAL
Intervention: 75 mg of DIM (300 mg of DIM-BR®) daily for 30 days
Number of subjects: 60
Study: 33901103

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 4295
Study: 35431172

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly for 52 weeks
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 32579613

Group type: EXPERIMENTAL
Intervention: NoHoW method
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Kalman imputation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Multiple imputation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Kalman method and NoHoW method
Number of subjects: 109
Study: 34544808

Group type: EXPERIMENTAL
Intervention: 6-month salsa dance training intervention, 2 weekly 1-hour sessions
Number of subjects: 180

Group type: COMPARATOR
Intervention: Regular fitness circuit training
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (passive comparator)
Number of subjects: 180
Study: 32539069

Group type: EXPERIMENTAL
Intervention: Internet-Distributed HIV Self-tests
Number of subjects: 1340

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 1340
Study: 34044584

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus enzalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enzalutamide plus placebo
Number of subjects: 0
Study: 32522126

Group type: EXPERIMENTAL
Intervention: Atole intervention
Number of subjects: 0
Study: 35780483

Group type: EXPERIMENTAL
Intervention: Mindfulness-based mandala activity (3 sessions)
Number of subjects: 170
Study: 32590057

Group type: EXPERIMENTAL
Intervention: Maternal mindfulness
Number of subjects: 105
Study: 32075832

Group type: EXPERIMENTAL
Intervention: Blended care programme (combining face-to-face consultations with web-based self-learning)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1200
Study: 32186977

Group type: EXPERIMENTAL
Intervention: Beef protein supplementation (BEEF), 25 g daily for 8 weeks
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Beef protein supplementation (BEEF)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Isoenergetic carbohydrates (CHO) supplement
Number of subjects: 6
Study: 33211769

Group type: EXPERIMENTAL
Intervention: Cupping therapy with negative pressure of 400 mmHg for 15 minutes, twice a week, for 4 weeks
Number of subjects: 18
Study: 36724180

Group type: EXPERIMENTAL
Intervention: Early active LV unloading
Number of subjects: 421

Group type: COMPARATOR
Intervention: Delayed active LV unloading
Number of subjects: 421
Study: 33744613

Group type: COMPARATOR
Intervention: Synb
Number of subjects: 1200

Group type: COMPARATOR
Intervention: PC
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Prob 2
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Prob 1
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: NC
Number of subjects: 1200
Study: 32286934

Group type: EXPERIMENTAL
Intervention: Inotersen
Number of subjects: 0
Study: 35446303

Group type: EXPERIMENTAL
Intervention: Qigong exercise program (n=22)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (n=27)
Number of subjects: 49
Study: 34176448

Group type: EXPERIMENTAL
Intervention: Buprenorphine/Naloxone (BUP-NX)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Extended-Release Injectable Naltrexone (XR-NTX)
Number of subjects: 79
Study: 33010767

Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional instrumentation (CI)
Number of subjects: 50
Study: 36257701

Group type: EXPERIMENTAL
Intervention: Educational screening intervention implemented in 15 primary care practices
Number of subjects: 85697

Group type: COMPARATOR
Intervention: Control group (practices not receiving the educational intervention)
Number of subjects: 85697

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 85697
Study: 34854982

Group type: EXPERIMENTAL
Intervention: Intradialytic cycling (IDC), 30 min of moderate intensity (RPE 12-14), thrice weekly for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 20
Study: 36178636

Group type: EXPERIMENTAL
Intervention: Daily step count
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 226
Study: 34105317

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36228695

Group type: EXPERIMENTAL
Intervention: CADe (ENDO-AID OIP-1)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard exploration (control)
Number of subjects: 370
Study: 34183742

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise (IG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nordic hamstring exercise (NG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 36434605

Group type: EXPERIMENTAL
Intervention: Saga Stories in health talks
Number of subjects: 450

Group type: COMPARATOR
Intervention: Standard health talk (Control)
Number of subjects: 450
Study: 34798808

Group type: EXPERIMENTAL
Intervention: Total NT-proBNP
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Ang2
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: BMP10
Number of subjects: 382
Study: 36241492

Group type: EXPERIMENTAL
Intervention: Malkia Klabu intervention (girl-friendly drug shops)
Number of subjects: 0